Background & Aims In 2018, our team initiated a prospective pilot program to challenge the
paradigm of the “6-month rule” of abstinence for patients with alcohol-related liver disease (…

Background & Aims There are conflicting reports on the outcomes after live donor liver
transplantation in patients with hepatocellular carcinoma (HCC). We aimed to compare the …

Nonalcoholic fatty liver disease (NAFLD) can occur de novo in patients undergoing liver
transplantation (LT) for indications other than NAFLD, and it has been increasingly recognized …

Background. Diabetes mellitus (DM) is said to adversely affect transplant outcomes. The
aim of this study was to investigate the impact of pre-existing and new-onset DM on liver …

Around the world, recommendations for cancer treatment are being adapted in real time in
response to the pandemic of COVID-19. We, as a multidisciplinary team, reviewed the …

Standard medical education dictates that the vast majority of cases of an alanine aminotransferase
(ALT) level> 1,000 IU/l will be due to acute ischaemia, acute drug-induced liver injury …

Paired organ exchange can be used to circumvent living donor‐recipient ABO incompatibilities.
Herein, we present the first case of successful liver paired exchange in North America. …

Importance The Model for End-stage Liver Disease (MELD)–based organ allocation system
has significantly decreased mortality on the transplant waiting list for patients with end-stage …

Background Liver transplantation (LT) remains the curative treatment for symptomatic Polycystic
Liver Disease (PCLD) patients and is associated with excellent survival rates. The aim …

Background. There is a lack of data on the use of direct-acting antivirals (DAA) on the risk of
death and tumoral recurrence in patients with hepatitis C virus (HCV) and hepatocellular …